| ncRNA name | hsa-miR-15a |
| ncRNA Category | miRNA |
| Disease name | diabetic retinopathy (DR) |
| Species | Homo sapiens |
| Tissues/Cell_line | human retinal endothelial cells (HRECs), human RPE cell line ARPE-19 |
| Methods | qRT-PCR, transfection, Western blot, immunostaining, luciferase reporter assay, in situ hybridizations (ISH) |
| Expression pattern | down-regulated |
| Functional description | We identified miR-15a as key regulator of both pro-inflammatory and pro-angiogenic pathways through direct binding and inhibition of the central enzyme in the sphingolipid metabolism, ASM, and the pro-angiogenic growth factor, VEGF-A. |
| PubMed ID | 27531575 |
| Year | 2016 |
| Title | Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy. |
| Drug-related ncRNA | NO |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.